Zur Rose AG (OTCMKTS:ZRSEF) was the target of a large increase in short interest in the month of August. As of August 31st, there was short interest totalling 113,800 shares, an increase of 35.0% from the August 15th total of 84,300 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
A number of analysts have recently weighed in on ZRSEF shares. Deutsche Bank restated a “buy” rating on shares of Zur Rose in a research note on Friday, July 17th. Barclays reaffirmed an “overweight” rating on shares of Zur Rose in a report on Tuesday, July 7th.
OTCMKTS ZRSEF opened at $307.00 on Thursday. Zur Rose has a 12 month low of $259.00 and a 12 month high of $310.03. The business has a 50-day moving average of $307.00.
About Zur Rose
Zur Rose Group AG operates an e-commerce pharmacy and a wholesale business for medical and pharmaceutical products under the Zur Rose and DocMorris brands in Germany, Switzerland, and rest of Europe. The company offers consumer health, beauty, and personal care products. It also provides medicines management services.
Recommended Story: Key terms to understand channel trading
Receive News & Ratings for Zur Rose Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zur Rose and related companies with MarketBeat.com's FREE daily email newsletter.